2-Amino-2-cyanoacetamide Chemical Properties

Melting point:

120-124 °C

Boiling point:

338.5±37.0 °C(Predicted)

Density 

1.298±0.06 g/cm3(Predicted)

storage temp. 

Store at <= 20°C.

form 

Powder

pka

17.05±0.50(Predicted)

color 

Beige to tan

Water Solubility 

soluble

Safety Information

Hazard Codes 

T,Xi,Xn

Risk Statements 

34-23-51-36-22

Safety Statements 

45-36/37/39-26

WGK Germany 

WGK 1 slightly water endangering

Hazard Note 

Irritant

HS Code 

2926 90 70

Toxicity

LD50 orally in Rabbit: > 2000 mg/kg

MSDS

• Language:English Provider:ACROS

2-Amino-2-cyanoacetamide Usage And Synthesis

Description

2-Amino-2-cyanoacetamide, a purine derivative with a diatomic molecule, has been shown to inhibit cancer cells in animals. It has been shown to inhibit the replication of plague virus, an RNA virus that causes encephalitis and other diseases in humans. The nitrogen atom on the molecule is responsible for its transport properties, including intestinal uptake and the ability to cross the blood-brain barrier.2-Amino-2-cyanoacetamide also inhibits the activity of amide hydrolase, an enzyme responsible for the hydrolysis of peptides into amino acids. This process results in reduced protein synthesis, which leads to cell death.

Chemical Properties

Beige Powder

Uses

2-Amino-2-cyanoacetamide is used as building block in chemical synthesis. Attributes Development Product Contact

Solubility in organics

soluble in ether and methanol.

2-Amino-2-cyanoacetamide(6719-21-7)Related Product Information

• 7-ACA-3-MTT-7-MO / 7-MAC,7-ACA-3-MTT-7-MO
• H-6-Aca-OH~epsilon-Aminocaproic acid~6-Aminohexanoic acid~EACA,h-6-aca-oh
• Boc-6-AMinocaproic acid
• 2-Amino-2-cyanoacetamide
• 7-ACA
• 7-Aca-3-SmtC10H12N6O6S3,7-aca-3-smt
• FMOC-6-ACA-OH
• ECPP-ACA
• alpha-Amylcinnamaldehyde
• Inositol
• 7-TMCA
• N-Benzyloxycarbonyl-6-aminohexanoic acid
• Hydroxymethyl-7-ACA
• 2-Cyanoacetamide
• GALNAC-BETA1,4(NEU5ACA-ALPHA2,8)(NEU5AC-ALPHA2,O3)GAL-BETA,4GLC-BETA1,1' CERAMIDE
• ACA DL-PHE(4-NO2)-OET
• Ultragel AcA-34
• ACA